Atlas Trials

A Study to Evaluate the Safety and Efficacy of Basmisanil in Adults With Severe Motor Impairment Following an Ischemic Stroke

Clinical trial NCT02928393 · TERMINATED

Trial details

NCT number
NCT02928393
Sponsor
Hoffmann-La Roche
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Stroke
Start date
2017-02-20
Primary completion
2017-11-03
Enrollment
5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.